Search
for
Sort by
Research 511–540 of 1000+
- Diverse mechanisms for endogenous regeneration and repair in mammalian organs
- Histopathology of alopecia: a clinicopathological approach to diagnosis
- Differential Expression of Fibromodulin, a Transforming Growth Factor-β Modulator, in Fetal Skin Development and Scarless Repair
- Anthracycline analogs The past, present, and future
- The pharmacology of methotrexate
- Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors
- Liposomal systems as drug delivery vehicles for dermal and transdermal applications
- Global Adiposity Rather Than Abnormal Regional Fat Distribution Characterizes Women with Polycystic Ovary Syndrome
- Smad7-Induced β-Catenin Degradation Alters Epidermal Appendage Development
- Physiologic skin changes in pregnancy
- Exosomes for repair, regeneration and rejuvenation
- The Role of Vitamins and Minerals in Hair Loss: A Review
- TGF-β family signaling in stem cells
- Hormesis and medicine
- Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
- Extracellular vesicles derived from MSCs activates dermal papilla cell in vitro and promotes hair follicle conversion from telogen to anagen in mice
- Modulation of Hair Growth with Small Molecule Agonists of the Hedgehog Signaling Pathway
- Hair Growth Cycle Affects Hair Follicle Destruction by Ruby Laser Pulses
- Baiting Proteins with C<sub>60</sub>
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- Androgens and androgen receptor action in skin and hair follicles
- Beyond acne: Current aspects of sebaceous gland biology and function
- The hair growth promoting effect of extract and its molecular regulation
- The Conundrum of Skin Pores in Dermocosmetology
- Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss
- Diagnosis of hyperandrogenism: clinical criteria
- Olfactory receptor OR2AT4 regulates human hair growth
- YAP and TAZ are essential for basal and squamous cell carcinoma initiation
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Repurposing of approved cardiovascular drugs